Upgrading Pacemakers for Better Heart Function
Official title: Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
Run by Imperial College London · NCT06052475 · Data updated 2026-11-12
This study tests if upgrading from a traditional pacemaker to a newer type can help people with heart problems feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 155 (estimated) |
| Sponsor | Imperial College London Academic / other |
| Locations | 12 sites (Cambridge and 11 other locations) |
| Status | Recruiting |
| Started | September 4, 2023 |
| Main results expected | September 30, 2026 |
| Study ends | September 4, 2027 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT06052475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with RV pacemakers, left ventricular ejection fraction (LVEF) between 35-50%, and a high burden of right ventricular pacing.
✕Probably not a fit
Patients who are unable to provide informed consent, those under 18, or pregnant women will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates whether patients with traditional right ventricular (RV) pacemakers and impaired heart function can improve their symptoms and quality of life by upgrading to a modern physiological pacing strategy. Participants will undergo a crossover design where they will initially continue with RV pacing before being randomized to either continue RV pacing or switch to physiological pacing for one-month periods. The study aims to assess the impact of this upgrade on heart function and patient-reported outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and heart function for patients with pacing-induced cardiomyopathy.
How similar studies have gone: Other studies have shown promising results with physiological pacing approaches, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients with an RV pacemaker and LVEF 35-50% and a high burden of right ventricular pacing (\>40%) who are clinically indicated for a cardiac resynchronisation therapy upgrade procedure and: 1. EF reduced by \>5% of increase in LVESV by 10ml since implant 2. NT-proBNP \>250ng/L in sinus rhythm 3. NT-proBNP \> 750 Ng/L if AF 4. Left atrial volume index \> 30ml/m2 5. Regular loop diuretics prescribed 6. Decline in daily patient activity by \>1 hour per day since implant 7. Decrease in device measured thoracic impedance 8. Patient reported decline in functional class or exercise tolerance Exclusion Criteria: * Those unable to provide informed consent * Patients under age 18 * Pregnant women
Where it's running
-
Royal Papworth Hospital
Cambridge, United Kingdom Recruiting -
St. Richard's Hospital - University Hospitals Sussex
Chichester, United Kingdom Recruiting -
University Hospitals Coventry and Warwickshire NHS Trust,
Coventry, United Kingdom Recruiting -
Croydon University Hospital - Croydon Health Services
Croydon, United Kingdom Recruiting -
Glenfield Hospital
Leicester, United Kingdom Recruiting -
Hammersmith Hospital
London, United Kingdom Recruiting
Show 6 more locations
-
King's College Hospital
London, United Kingdom Recruiting -
St Bartholomew's Hospital - Barts Health NHS Trust
London, United Kingdom Recruiting -
Oxford University Hospitals
Oxford, United Kingdom Recruiting -
University Hospitals Southampton
Southampton, United Kingdom Recruiting -
Great Western Hospitals
Swindon, United Kingdom Recruiting -
Worthing Hospital - University Hospitals Sussex
Worthing, United Kingdom Recruiting
Study contacts
- Principal investigator: Daniel Keene, PhD — Imperial College London
- Study coordinator: Aya Khalil
- Email: a.khalil@imperial.ac.uk
- Phone: 07749576830
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
Pacing decisions guided by risk for pacing-induced heart muscle weakness
This study tests a risk score to predict pacing-induced cardiomyopathy in adults getting heart rhythm devices, to tailor pacing choices.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing two pacing methods for heart failure in patients with atrial fibrillation
This study is testing whether a new pacing method for the heart can work better than the standard method for people with heart failure and atrial fibrillation.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Comparing His and Left Bundle Branch Pacing for Heart Failure
This study is testing whether a new way of pacing the heart can help people with heart failure feel better and stay out of the hospital compared to the usual treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.